Mutation Key to Aspirin’s Role in Colon Cancer

Aspirin may help to treat colon cancer among people who have a particular gene mutation, a new study suggests. The study focused on 964 people with colon cancer. As participants in 2 long-term health studies, they recorded what medicines they took. Researchers looked at the genes in people’s colon cancer tumors. They focused on a gene called PIK3CA. This gene is involved in one pathway that promotes the growth of cancer. Aspirin seems to interfere with this pathway. Researchers found that some people in the study had a mutation in the PIK3CA gene. In the first 5 years after diagnosis, 2 of the 62 regular aspirin users with the mutated gene died. In contrast, 23 of 90 people who had the mutation but did not take aspirin died. Researchers also looked at longer-term survival.

Content restricted. Requires subscription

Study Says Lower Vitamin D Levels OK

Almost 80 million Americans don’t have low vitamin D levels after all, an expert group says. The new, lower guidelines on vitamin D come from the Institute of Medicine. This is an independent group that provides research-based advice on medical care. Current guidelines don’t agree on what blood level of vitamin D is too low. For example, the Endocrine Society says that people should have at least 30 nanograms of vitamin D per milliliter of blood (ng/ml). Anyone with lower levels may need vitamin D pills, the group says. The new Institute of Medicine guidelines say that 20 ng/ml is enough. An estimated 78.7 million American have levels between 20 and 30. The new study included more than 15,000 adults. Information about them came from a major health survey. This was compared with a national death registry.

Content restricted. Requires subscription

Weight Loss Disappoints in Study of Diabetics

A study of diabetics has been stopped early because an intensive diet and exercise program did not reduce their risk of heart attack or stroke. Adults with type 2 diabetes have twice the risk of these problems as other adults. The study included 5,145 overweight or obese adults with type 2 diabetes. They were randomly divided into 2 groups. One group followed a strict diet. People were limited to 1,200 to 1,800 calories a day. They also did 175 minutes a week of moderate exercise. The other group just received general diabetes education and support. People in the first group lost about 10% of their weight at first. They kept off about 5% for at least 4 years. Other research has shown that a 5% weight loss can reduce factors that affect heart and stroke risk. People in the second group lost about 1% of their weight. After 11 years, U.S.

Content restricted. Requires subscription

Puberty Starting Earlier for Boys

American boys, like girls, may be entering puberty earlier than they did 30 to 40 years ago, a new study finds. Based on prior research, doctors have considered 11½ to be the average age of puberty for boys. In the new study, the average was about 10 for whites and Hispanics. The average was 9 for blacks, about 2 years earlier than prior studies showed. The new study was based on exams of more than 4,000 boys. Their ages ranged from 6 to 16. Doctors in 41 states recorded information during well-child visits. They took note of pubic hair, genital size and testicle size. Growth of testicles is considered the first sign of puberty for boys. Other research has shown that puberty in girls is starting sooner. This may lead to a higher risk of breast cancer. It’s unclear why early puberty may be happening in boys, researchers said.

Content restricted. Requires subscription

Pharmacy Probe Expands; Deaths Rise to 20

U.S. drug regulators have expanded their investigation of a pharmacy linked to an outbreak of meningitis. The New England Compounding Center of Framingham, Mass., has been shut down since last month. At least 250 cases of meningitis caused by a fungus have been linked to steroid shots made at the pharmacy. Most of them were linked to a fungus called Exserohilum rostratum. The infections have caused at least 20 deaths. The Food and Drug Administration (FDA) confirmed October 18 that this fungus was found in one lot of steroid vials made by the company. The FDA also said it is looking into the cause of infections among 3 people who received other kinds of drugs made by New England Compounding. The fungus involved in the steroid injections is commonly found in nature. FDA still is looking into how it could have contaminated the drugs used to produce the steroid shots.

Content restricted. Requires subscription